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Abstract Matrix metalloproteinases (MMPs) regulate
connective tissue architecture and cell migration through
extracellular matrix (ECM) degradation and are associated
with both physiological and pathological processes.
Although they are known to play a role in skeletal deve-
lopment, little is known about the role of MMPs in inter-
vertebral disc (IVD) development. Sixteen fetal human
lumbar spine segments, obtained at autopsy, were com-
pared with ﬁve normal, non-fetal L4–L5 IVDs. Intensity
and/or localization of immunohistochemical staining for
MMP-1, -2, -3 and -14 were evaluated by three indepen-
dent observers. MMP-2 production and activation was
quantiﬁed by gelatin zymography. MMP-1 and -14 were
abundantly present in the nucleus pulposus (NP) and
notochordal (NC) cells of the fetal IVDs. In non-fetal
IVDs, MMP-1 and -14 staining was signiﬁcantly less
intense (p = 0.001 and p\0.001, respectively). MMP-3
was found in almost the entire IVD with no signiﬁcant
difference from non-fetal IVDs. MMP-2 staining in the NC
and NP cells of the fetal IVD was moderate, but weak in
the non-fetal IVD. Gelatin zymography showed a negative
correlation of age with MMP-2 activity (p\0.001).
MMP-14immunostainingcorrelatedpositivelywithMMP-2
activity (p = 0.001). For the ﬁrst time, the presence of
MMP-1, -2, -3 and -14 in the fetal human IVD is shown
and the high levels of MMP-1, -2 and -14 suggest a role in
the development of the IVD. In particular, the gradual
decrease in MMP-2 activation during gestation pinpoints
this enzyme as key player in fetal development, possibly
through activation by MMP-1 and -14.
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Introduction
Since the identiﬁcation of the ﬁrst matrix metalloproteinase
(MMPs) in 1962, MMPs have been shown to be associated
with a large number of diseases, including vascular, renal,
neurological, respiratory, oncological, rheumatic and
orthopedic diseases [1, 2]. However, the development of
MMP knock-out mice with aberrant phenotypes and the
severe side effects of MMP inhibitors in the late 1990s
clearly indicated that MMPs are also crucial for normal
tissue function [1, 2]. MMPs are associated with complex
regulatory processes such as cell migration, tissue archi-
tecture and development [2, 3]. Fetal development of
connective tissues has also been suggested to be dependent
on this class of enzymes and various MMPs have been
shown to play a role in skeletal development.
Various MMPs have been shown to be involved in the
development of joints. MMP-1 was found in chondrocytes
and synovium of fetal human joints [4]. Moreover, MMP-1
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of fetal horses compared to juvenile and mature animals
[5]. MMP-2 is associated with development of the osteo-
cytic canalicular network, synovial tissue and articular
surfaces [4, 6]. In humans, a mutation in the gene encoding
for MMP-2 results in a multicentre osteolysis and arthritis
syndrome, which is characterized by short stature, facial
anomalies, and arthropathy [7]. MMP-3 has been associ-
ated with the development of fetal joints and of joint
cavities. An increase in MMP-3 activity was found in the
synovial ﬂuid of fetal equine joints compared to juvenile
and mature horses [4, 8]. The most severe phenotypical
abnormalities of all MMP-deﬁcient animals are seen in the
MMP-14 knock-out mouse, characterized by dwarﬁsm,
osteopenia, arthritis, angiogenesis defects and death within
3–12 weeks after birth [9]. Remodeling of fetal unminera-
lized cartilage into joints and bone has been shown to be
MMP-14-mediated [10].
However, nothing is known about the involvement of
MMPs in fetal development of the intervertebral disc
(IVD). As the extracellular matrix (ECM) of both articular
cartilage and the nucleus pulposus (NP) of the IVD is
mainly composed of aggrecan and collagen type II, and the
respective degenerative processes have been shown to
share many factors, it is likely that also during fetal
development, cartilage and IVD tissue share the same
mediators [11].
Given this clear association of MMP-1, -2, -3 and -14
with the fetal development of cartilage, the aim of this
study was to evaluate their presence and in particular the
activity of MMP-2 in human IVDs during consecutive
stages of fetal development and compare these to normal
non-fetal IVDs.
Materials and methods
Reagents, antibodies and tissue processing
Used reagents, antibodies, antibody concentrations, antigen
retrieval and tissue processing are described in the elec-
tronic supplement.
Sample acquisition
Fetal IVDs were obtained during a standard post-mortem
procedure in which the lumbar spine is partly removed for
diagnostic purposes. IVDs from 16 deceased patients
(spontaneous abortions, gestation age 15.5–40.3 weeks)
were obtained within 24 h after death (supplemental
Table 1). Patients with skeletal pathology were excluded
from this study. Several lumbar segments, including the
vertebrae and adjacent endplates, were obtained. A control
group of ﬁve non-fetal, non-degenerative, human L4–L5
IVDs (age 3.3–21.8 years) was collected in a similar
manner as the fetal IVDs. This control group will be
referred to as the non-fetal discs. The scientiﬁc committee
from the Department of Pathology of the UMC Utrecht
approved the study and the material was used in line with
the code ‘‘Proper Secondary Use of Human Tissue’’ as
installed by the Federation of Biomedical Scientiﬁc
Societies.
After resection, the discs were cut (fetal discs) or sawed
(non-fetal discs) in sagittal samples. Of each IVD, a mid-
sagittal sample was ﬁxed and stored in 4% formalin for
histology. The remaining sagittal slices were embedded in
TissueTek (Sakura Finetek Europe, Zoeterwoude, The
Netherlands), stored at -80C and were used for protein
extraction.
Immunolocalization of MMP-1, -2, -3, -14, collagen
type II, endothelial membrane antigen (EMA)
and pan cytokeratin (AE1/AE3)
Parafﬁn sections were rehydrated through xylene and gra-
ded ethanol series. Endogenous peroxidase was inactivated
by incubation in 0.3% H2O2 in PBS for 15 min, followed
by a 20-min block step with PBS/3% BSA. Sections were
incubated with primary antibodies and the appropriate
secondary antibody. DAB (0.06%) in PBS was used for
antigen detection and sections were counterstained with
Mayer’s hematoxylin. Negative controls were incubated
with isotype controls at the same IgG concentration.
Immunohistochemical staining for MMP-1, -2, -3 and
-14 was graded by three independent observers according a
semiquantitative four-point scoring scale [12]. An intense
staining for the antigen in[50% of the cells was scored as
??, an intense staining in 10–50% of the cells was scored
?, ± was scored if the staining was seen in less than 10%
of the cells and - was scored when no staining was
observed. In each section, the cartilage endplate (CE), NP,
AF, and notochordal (NC) cells were analyzed. Scores of
the three observers were averaged and outliers, i.e. more
than 1 grade difference, were re-evaluated at a consensus
meeting.
Collagen type II immunohistochemistry was used to
demonstrate the cartilaginous nature of the ECM through-
out the fetal and non-fetal IVDs (Supplemental Fig. 2e, f).
The EMA and pan cytokeratin (AE1/AE3) staining was
used for identiﬁcation of NC cells [13, 14].
Gelatin zymography for MMP-2 activation
and production
Fivemicrogramsofproteinoftissueextractwasseparatedon
an 8% acrylamide/0.1% gelatin gel. After electrophoresis,
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50 mM Tris and 10 mM CaCl (pH 7.4) and incubated for
18 hin0.05%Brij35,50 mMTris,10 mMCaCl(pH7.4)at
37C. Gels were stained with Coomassie Brilliant Blue,
destained in deionized water and analyzed by densitometry
using the Gel doc 2000 system (Bio-rad, Hercules, CA) and
Quantity One software (Bio-rad). A degenerative IVD
sample containing active and pro-MMP-2 was used as con-
trol sample. Densitometry data were corrected to the mea-
surements of the control sample on each gel. Gelatin
zymography of both fetal and non-fetal samples is shown in
supplemental Fig. 3. Casein zymography for MMP-1 and
MMP-3wasalsoattempted;however,thistechniquewasnot
sensitiveenoughtodetectMMP-1orMMP-3activityinfetal
and non-fetal IVDs.
Statistical analysis
Statistical analysis was performed with SPSS 12.0.1 soft-
ware. Differences in enzyme content between fetal and
non-fetal IVDs were determined by a Mann–Whitney U
test. Differences between age groups were analyzed by
Kruskal–Wallis’ non-parametric test followed by non-
parametric multiple comparison test and Bonferroni
correction. Spearman’s non-parametric test was used for
correlation analyses. Categorical data obtained by grading
of the immunochemical staining were analyzed with the
2 9 C Fisher exact test [15].
Results
Immunohistochemistry
In the non-fetal IVDs, NC cells, identiﬁed by their mor-
phology of large irregularly shaped cells containing vesi-
cle-like structures predominantly laying in cell clusters
(Fig. 1a) [16, 17], were found to stain positive for EMA
and pan cytokeratin (AE1/AE3), which did not stain any
other cell type (Fig. 1b, c, respectively). Abundant staining
for MMP-1 was seen in the NP of the fetal IVD, whereas
staining of the AF and CE was less intense (Fig. 2a). In the
fetal NP, both the chondrocyte-like NP cells and the NC
cells stained positive for MMP-1(Fig. 2a). In the non-fetal
IVDs, MMP-1 staining was moderately positive in NP and
AF, while no staining was seen in the CE (Fig. 2b). The
positive staining in the NP was mainly localized in the NC
cells (Fig. 2b). The intensity of the immunohistochemical
staining in all three areas of the IVD (CE, AF and NP)
combined was signiﬁcantly higher in the fetal IVDs com-
pared to the non-fetal IVDs, p = 0.001 (Fig. 3). MMP-2
staining was moderate in the NP, in both chondrocyte-like
NP and NC cells, of the fetal IVDs, whereas no staining
was found in the CE and AF (Fig. 2c). MMP-2 staining in
the non-fetal IVDs was variable throughout the IVD, with
in general a moderate to weak staining in the entire IVD
(Fig. 2d).
MMP-3 was clearly seen in the NP, AF and CE of fetal
IVDs (Fig. 2e). Intense staining of the NC cells and a
moderate staining of chondrocyte-like NP cells were seen
in the NP (Fig. 2e). In the non-fetal IVDs, MMP-3 staining
was seen in the NP and moderately in the CE and AF. In
the NP the NC cells showed a clear staining and the
chondrocyte-like NP cells showed a moderate staining for
MMP-3 (Fig. 2f).
The intensity of MMP-14 staining in the fetal IVDs was
strong in the NP and moderate in the AF and CE. In the NP,
both the NC and chondrocyte-like NP cells stained positive
for MMP-14 (Fig. 2g). In the non-fetal IVDs, the NP
showed a moderate staining and the AF and CE were
negative (Fig. 2h). In the NP, the NC cells were still clearly
positive for MMP-14, but a few cartilage-like NP cells
were also positive for MMP-14 (Fig. 2h). The intensity of
the staining in all three areas of the non-fetal IVDs com-
bined was signiﬁcantly less than in the fetal IVDs,
p B 0.001 (Fig. 3).
Gelatin zymography for MMP-2 activation
and production
Gelatin zymography showed a statistically signiﬁcant nega-
tive correlation between age in weeks and active MMP-2
[p\0.001; correlation coefﬁcient (CC) -0.80]. Also with
respect to fetal development only (ﬁrst 3 age groups), a
negative correlation was found for MMP-2 activity and
gestational age (p = 0.013 CC =- 0.61). No correlation
was found between levels of pro-MMP-2 and age. The level
of active MMP-2 in the fetal groups was higher in
Fig. 1 Hematoxylin–eosin
staining of NC cells in the fetal
intervertebral disc (a).
Identiﬁcation of NC cells by
positive immunohistochemical
staining for EMA (b) and CK
AE1/AE3 (c). Scale bars
represent 25 lm( a, b) and
100 lm( c)
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levels of pro-MMP-2 were signiﬁcantly higher in fetal
samples compared to non-fetal discs (p = 0.008) (Fig. 4).
A signiﬁcant decrease in active MMP-2 was found
between the 15–22 weeks after gestation group and the
non-fetal group (0–22 years, p\0.001). The level of pro-
MMP-2 was signiﬁcantly higher in 30–41 weeks after
gestation group, compared to the IVDs from the non-fetal
group (0-22 years, p = 0.044). Active MMP-2 levels in all
IVD samples showed a strong positive correlation with the
intensity of MMP-14 immunohistochemistry (p = 0.001,
CC = 0.673). Faint MMP-9 bands were found in most
samples, no differences in active and pro-MMP-9 levels
were seen between fetal and non-fetal IVDs.
Fig. 2 Immunohistochemical
staining for MMP-1 (a, b),
MMP-2 (c, d), MMP-3 (e, f) and
MMP-14 (g, h) in the nucleus
pulposus of fetal (a, c, e, g) and
non-fetal IVDs (b, d, f, h).
Arrows accompanied by ‘‘NC’’
indicate clusters of notochordal
cells and within the nucleus
pulposus and ‘‘NP’’ indicates
the nucleus pulposus containing
chondrocyte-like NP cells. Scale
bars represent 100 lm( a, b, e,
f), 50 lm( g, h) and
25 lm( c, d)
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This study for the ﬁrst time shows the presence of MMP-1,
-2, -3 and -14 in fetal and non-fetal human IVDs. The
enzymes were mainly localized in the NP and in the NC
cells of the IVD. Signiﬁcantly, more MMP-1 and -14 were
seen in the fetal IVDs compared to the non-fetal IVDs.
Moreover, MMP-2 activity during fetal development was
high during the ﬁrst 15–22 weeks of gestation and
decreased with gestational age and even further in postnatal
and young healthy IVDs.
Not much is known about the presence of MMPs in fetal
and non-fetal IVDs. An immunohistochemical study
describing the presence of MMP-1, -2, -3 and -9 in
degenerative human IVDs included some data on an
unknown number of fetal and non-fetal IVDs of donors of
undeﬁned age [18]. In contrast to the present data, these
MMPs were not found in fetal IVDs and only an occasional
staining for MMP-1, -2 and -3 was reported in non-
degenerative IVDs [18]. The discrepancies with this study
could be explained by various factors such as different and
less sensitive immunohistochemistry protocols and the
limited number of fetal and non-degenerative IVDs in the
degenerative disc study.
In this study, it was shown that these enzymes are
present in the fetal IVD and that their levels decreased
during childhood and adolescence, suggesting a physio-
logical function of these enzymes during development of
the IVD. In support of this role is the available literature on
MMP-1, -2, -3 and -14, clearly associating these enzymes
Fig. 3 Intensity of immunohistochemical staining for MMP-1, -2, -3
and -14 in fetal and non-fetal IVDs. An intense staining for the
antigen in[50% of the cells was scored as ??, an intense staining in
10–50% of the cells was scored ?, ± was scored if the staining was
seen in less than 10% of the cells and - was scored when no staining
was observed, **p\0.005
Fig. 4 Amount of active and pro-MMP-2 in fetal and non-fetal IVDs.
Error bars represent standard error of the mean, *p\0.05
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cartilaginous tissue. The function of these MMPs during
the fetal development of the IVD could be: direct ECM
degradation for cell migration or tissue remodeling, regu-
lation of the activity of other proteases by removal of the
pro-domain and modulation of biologically active mole-
cules by direct cleavage or release from ECM store [19].
MMP-14 is the only MMP, which has speciﬁcally been
studied in non-degenerative IVDs. A rat IVD organ culture
study describes the presence of MMP-14 in chondrocytes
migrating from the CE to the NP and an extensive immu-
nohistochemical positivity of the NC cells for MMP-14 is
reported [20], in concordance with the current results. The
authors suggest that MMP-14 enables the chondrocytes to
migrate from the CE to the NP and replace the NC cells
[20]. During growth of the IVD, the normal ECM has to be
degraded to allow IVD cells to migrate through the tissue
[21]. Additionally, existing ECM could undergo partial or
complete degradation prior to new matrix synthesis [21].
MMP-1, -2, -3 and -14 are all capable of degrading one or
both of the most important ECM components of the fetal
IVD, collagen type II and aggrecan.
Besides their role in remodeling by ECM degradation,
several MMPs also have regulatory functions by activating
other proteases [2]. In the developing IVD, MMP-1 and -14
could have a regulatory function since both enzymes are
capable of activating several MMPs including MMP-2 [22].
Additionally, regulatory activity of MMP-1 could be regu-
lated by MMP-3which is capable of not only activating pro-
MMP-1 but also pro-MMP-7, -8, -9 and -13 [22]. The
strongly abnormal phenotype of several MMP knock-out
mice may well be caused by these important regulatory
functions of the enzymes. In particular, MMP-14 knock-out
mice display decreased proliferation of chondrocytes in
growth plates and defective vascular invasion of cartilage
ends of fetal long bones, which leads to shortening and
skeletal malformation [9, 23]. The decreased activation of
MMP-2 in MMP-14-deﬁcient mice suggests that the func-
tion of MMP-14 during development may not just be limi-
ted to ECM turnover and that MMP-14 also has a more
regulatory function [23]. The statistically signiﬁcant cor-
relation between MMP-2 activity and the intensity of MMP-
14 immunohistochemistry could be an indication that
MMP-2 activity in fetal IVDs is regulated by MMP-14.
Strikingly, MMP-14 and -1 were clearly present in the
NC cells of the fetal IVD, suggesting a possible role for
these cells in the regulation of extracellular remodeling and
cell migration. This theory is supported by the fact that the
loss of these cells during late childhood or adolescence is
associated with the onset of IVD degeneration [24].
Moreover, recently rat NC cells have been found to stimu-
late migration of rat CE chondrocytes in vitro [25]. NC
cells are remnants of the embryonic notochord and are
entrapped inside the IVD during embryonic formation of
the vertebrae and IVDs [17]. There are two hypotheses on
the role of NC cells during IVD development. The ﬁrst
postulates that NC cells regulate matrix synthesis and cell
migration and undergo apoptosis once disc formation is
complete. The second theory assumes that NC cells directly
synthesize the ECM of the NP and then differentiate into
chondrocyte-like NP cells [17]. Since the NC cells were
found to stain less intense for proteoglycans than the
chondrocyte-like NP cells and hardly any staining for
collagen type II is seen in the ECM surrounding the NC
cells, the ﬁrst theory seems to be most likely.
Although this study clearly shows the presence of MMP-
1, -2, -3 and -14 in the fetal IVD, it must be kept in mind
that immunohistochemistry is seldom capable of distin-
guishing between active and inactive forms of enzymes.
Only the actual activity of MMP-2 could be determined
here, whereas casein zymography and ELISA-based
activity assays were not sensitive enough to measure
detectable levels of enzyme activity. Although PCR is a
very sensitive technique, the presence mRNA levels do not
always correlate to the protein levels and PCR is unable to
detect the presence of active MMPs. More sensitive tech-
niques determining actual MMP activity are required to
further elucidate the role of MMPs in IVD development.
As to the clear association of IVD development with
MMP-2 activity, it remains unknown how MMP-2 exactly
is involved in IVD, or even cartilage or joint development.
A role in ECM turnover and growth seems likely; however,
no support for this hypothesis can be found in literature. It
is remarkable that MMP-2 seems to have such a close
association with the development of connective tissues and
is also strongly associated with degenerative diseases as
osteoarthritis and IVD degeneration [26]. MMP knock-out
mice studies could further elucidate the role of MMPs in
fetal IVD development; however, results of these studies
should be analyzed with care since human and mice MMPs
are not entirely comparable.
In addition to the MMPs studied, other proteases may be
involved in fetal development of the IVD. However, the
enzymes currently studied are the only MMPs shown to be
involved in the development of cartilage and joints.
ADAMTS-4 and -5 may provide good candidates for IVD
development through ECM turnover. Nevertheless, neither
of these enzymes have been shown to be required for
normal cartilage and skeletal development as demonstrated
in knock-out models [27].
Conclusion
This study clearly shows the presence of MMP-1, -2, -3 and
-14 in the fetal human IVD. Their increased expression as
Eur Spine J (2010) 19:1340–1346 1345
123compared to non-fetal healthy IVDs suggests their
involvement in IVD development. In particular, MMP-2
activity was closely correlated to developmental stage.
During IVD development, MMPs could be involved in cell
migration, regulation of ECM turnover and activation of
other MMPs.
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